Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 556 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves Reyataz labeling change

The label will now include warnings about kidney and gall stones in addition to updated information regarding drug interaction. Interstitial nephritis, where in the spaces between the kidney